Action 688238 OBIO TECHNOLOGY (SHANGHAI) CORP., LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Obio Technology (Shanghai) Corp., Ltd.

Actions

688238

CNE1000059N9

Cours en clôture Shanghai S.E.
Autres places de cotation
 00:00:00 25/06/2024 		Varia. 5j. Varia. 1 janv.
4,65 CNY -2,11% Graphique intraday de Obio Technology (Shanghai) Corp., Ltd. -6,06% -48,28%
30/05 OBiO Technology lance officiellement le Centre d'évaluation clinique et de traduction des thérapies avancées pour les maladies rares et génétiques pédiatriques CI
28/04 Obio Technology (Shanghai) Corp, Ltd. annonce ses résultats pour le premier trimestre clos le 31 mars 2024 annonce ses résultats pour le premier trimestre clos le 31 mars 2024 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Fubara Appoints Caretaker Chairpersons for Rivers Lgas
Tension in Rivers... Fubara, Council Chairmen Flex Muscles Over Tenure Expiration
Mayhem in Rivers As Wike, Fubara Feud Spills to LG HQs
Amaechi Has Lost 70% of Political Followership in Rivers - APC Chieftain
OBiO Technology Officially Launches the Center for Clinical Evaluation and Translation of Advanced Therapies for Pediatric Rare and Genetic Diseases
Obio Technology's Shareholders to Offload Up to 1.5% Stake
Obio Technology Corp., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Voyce, Hamilton Health Sciences and OBIO Showcase Breakthrough in Patient Care through Language Access Technology
OBIO - CHEO selects PolyUnity for 3D Printing Solution
OBIO Celebrates International Women's Day with Investment in Three Women-Led Companies and a Successful Graduation of First Seed Funding Cohort
Obio Technology Corp., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
OBIO Celebrates the Advancement of Women in Health Science with WiHI Seed Program and Leadership Awards
OBIO launches national health science technology training program powered by Upskill Canada
Obio Technology Corp., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
OBiO Announces Strategic Partnership with Refreshgene to Realize Commercialization of Gene Therapy Product
Obio Launches Gmp Production Facility Intelli-M to Expedite Innovative and Advanced Therapies to Patients Who Are in Need
Ontario Bioscience Innovation Organization - OBIO opens applications for its newly-launched Life Sciences Critical Technologies and Commercialization Centre of Excellence
ONTARIO BIOSCIENCE INNOVATION ORGANIZATION
Obio Technology Corp., Ltd.(XSSC:688238) added to S&P Global BMI Index
Obio Technology Corp., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 688238
  4. Actualités Obio Technology (Shanghai) Corp., Ltd.
  5. Autres langues